Waters Corporation  

(Public, NYSE:WAT)   Watch this stock  
Find more results for WAT
124.11
+2.26 (1.85%)
Mar 27 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 121.78 - 124.28
52 week 93.56 - 125.02
Open 122.27
Vol / Avg. 346,782.00/366,972.00
Mkt cap 10.30B
P/E 24.46
Div/yield     -
EPS 5.07
Shares 83.03M
Beta 0.84
Inst. own 92%
May 11, 2015
Waters Corporation Annual Shareholder Meeting (Estimated) Add to calendar
Apr 27, 2015
Q1 2015 Waters Corp Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Mar 3, 2015
Waters Corp at Cowen Health Care Conference
Feb 12, 2015
Waters Corp at Leerink Global Healthcare Conference
Jan 26, 2015
Q4 2014 Waters Corp Earnings Call - Webcast
Jan 26, 2015
Q4 2014 Waters Corp Earnings Release
Jan 12, 2015
Waters Corp at JPMorgan Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 25.91% 21.70%
Operating margin 29.47% 26.03%
EBITD margin - 31.33%
Return on average assets 15.91% 11.57%
Return on average equity 32.48% 23.60%
Employees 6,200 -
CDP Score - 71 D

Address

34 MAPLE ST
MILFORD, MA 01757-3604
United States - Map
+1-508-4782000 (Phone)
+1-508-8721990 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Waters Corporation is an analytical instrument manufacturer that primarily designs, manufactures, sells and services, through its Waters Division, high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans. The Company operates in two segments: Waters Division and TA Division. Through its TA Division (TA), the Company primarily designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments. The Company's products are used by pharmaceutical, life science, biochemical, industrial, nutritional safety, environmental, academic and governmental customers working in research and development, quality assurance and other laboratory applications.

Officers and directors

Douglas A. Berthiaume Chairman of the Board, President, Chief Executive Officer
Age: 66
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Eugene G. Cassis Chief Financial Officer
Age: 58
Bio & Compensation  - Reuters
Arthur G. Caputo Executive Vice President, President - Waters Division
Age: 63
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Mark T. Beaudouin Vice President, General Counsel, Secretary
Age: 60
Bio & Compensation  - Reuters
Elizabeth B. Rae Vice President - Human Resources
Age: 57
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Thomas P. Salice Lead Independent Director
Age: 54
Bio & Compensation  - Reuters
Joshua Bekenstein Independent Director
Age: 55
Bio & Compensation  - Reuters
Michael Joseph Berendt Ph.D. Independent Director
Age: 65
Bio & Compensation  - Reuters
Edward W. Conard Independent Director
Age: 57
Bio & Compensation  - Reuters
Laurie H. Glimcher M.D. Independent Director
Age: 62
Bio & Compensation  - Reuters